Virax Biolabs Group Ltd (NASDAQ:VRAX) currently has a daily average trading volume of 3.27M but it saw 45890439 shares traded in last market. With a market cap of 15.10M USD, the company’s current market price of $6.40 came rising about 79.78 while comparing to the previous closing price of $3.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.00 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $3.29 while lowest mark touched by it was $6.4.
Taking a look at 20-day trading activity of Virax Biolabs Group Ltd (VRAX) gives us an average price of $1.85, while its current price level is -28.89% below from 52-week high level whereas it is 966.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.53 while that of 200 days or SMA-200 reads an average of $1.27. A closer look into the stock’s movement over the week reveals that its volatility is standing at 62.91% during that period while stretching the period over a month that decreases to 31.68%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 76.93 which implies that the stock is in overbought territory.
Over the week, VRAX’s stock price is moving 269.94% up while it is 442.37% when we observe its performance for the past one month. Year-to-date it is 338.36% up and over the past year, the stock is showing an upside performance of 77.78%.
Currently, Virax Biolabs Group Ltd’s total number of outstanding shares is 2.57M. Company’s return on investment (ROI) stands at -121.48% and return on equity (ROE) at -92.92%. Stock’s beta reads 1.57. Stock has a price to book (P/B) ratio of 3.07 while price to sale or P/S ratio amounts to 94.40. Its return on asset (ROA) is -88.04% on average.
